Loss of Expression and Promoter Methylation of SLIT2 Are Associated with Sessile Serrated Adenoma Formation

PLoS Genetics

Volumn 9, Issue 5, 2013, Pages

  Beggs, Andrew D ^a,b,c   Jones, Angela ^a   Shepherd, Neil ^d   Arnaout, Abed ^b   Finlayson, Caroline ^e   Abulafi, A Muti ^b   Morton, Dion G ^c   Matthews, Glenn M ^c   Hodgson, Shirley V ^f   Tomlinson, Ian P M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^e ST GEORGE S HOSPITAL   (United Kingdom)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SLIT2 PROTEIN;

ADENOMA; ADULT; AGED; ARTICLE; CHROMOSOME 4P; COLON ADENOMA; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE; GENE EXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PDCH7 GENE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PYROSEQUENCING; RECTUM ADENOMA; SLIT2 GENE;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LINKAGE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS;

EID: 84878517659     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003488     Document Type: Article

References (27)

1. Leggett B, Whitehall V, Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138: 2088-2100.
2. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP, (2005) Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol 124: 380-391.
3. Rex DK, Ahnen DJ, Baron JA, Batts KP, Burke CA, et al. (2012) Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel. Am J Gastroenterol.
4. Torlakovic EE, Gomez JD, Driman DK, Parfitt JR, Wang C, et al. (2008) Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol 32: 21-29.
5. Carr NJ, Mahajan H, Tan KL, Hawkins NJ, Ward RL, (2009) Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 62: 516-518.
6. Chan TL, Zhao W, Leung SY, Yuen ST, (2003) BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 63: 4878-4881.
7. Jass JR, Baker K, Zlobec I, Higuchi T, Barker M, et al. (2006) Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Histopathology 49: 121-131.
8. O'Brien MJ, Yang S, Mack C, Xu H, Huang CS, et al. (2006) Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30: 1491-1501.
9. Vandrovcova J, Lagerstedt-Robinsson K, Pahlman L, Lindblom A, (2006) Somatic BRAF-V600E mutations in familial colorectal cancer. Cancer Epidemiol Biomarkers Prev 15: 2270-2273.
10. Fu B, Yachida S, Morgan R, Zhong Y, Montgomery EA, et al. (2012) Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon. Am J Clin Pathol 138: 356-366.
11. Kim GE, Lee KH, Choi YD, Lee JS, Lee JH, et al. (2011) Detection of Slit2 promoter hypermethylation in tissue and serum samples from breast cancer patients. Virchows Arch 459: 383-390.
12. Zhou WJ, Geng ZH, Chi S, Zhang W, Niu XF, et al. (2011) Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis. Cell Res 21: 609-626.
13. Beggs AD, Jones A, El-Bahwary M, Abulafi M, Hodgson SV, et al. (2012) Whole-genome methylation analysis of benign and malignant colorectal tumours. J Pathol.
14. Shivapurkar N, Maitra A, Milchgrub S, Gazdar AF, (2001) Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma. Hum Pathol 32: 169-177.
15. Shivapurkar N, Sood S, Wistuba, II, Virmani AK, Maitra A, et al. (1999) Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas. Cancer Res 59: 3576-3580.
16. Shivapurkar N, Virmani AK, Wistuba II, Milchgrub S, Mackay B, et al. (1999) Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma. Clin Cancer Res 5: 17-23.
17. Dallol A, Da Silva NF, Viacava P, Minna JD, Bieche I, et al. (2002) SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res 62: 5874-5880.
18. Dallol A, Morton D, Maher ER, Latif F, (2003) SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer Res 63: 1054-1058.
19. Prasad A, Paruchuri V, Preet A, Latif F, Ganju RK, (2008) Slit-2 induces a tumor-suppressive effect by regulating beta-catenin in breast cancer cells. J Biol Chem 283: 26624-26633.
20. Prasad A, Qamri Z, Wu J, Ganju RK, (2007) Slit-2/Robo-1 modulates the CXCL12/CXCR4-induced chemotaxis of T cells. J Leukoc Biol 82: 465-476.
21. Forcet C, Ye X, Granger L, Corset V, Shin H, et al. (2001) The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation. Proc Natl Acad Sci U S A 98: 3416-3421.
22. Azuara D, Rodriguez-Moranta F, de Oca J, Sanjuan X, Guardiola J, et al. (2012) Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients. Inflamm Bowel Dis.
23. Jones PA, Laird PW, (1999) Cancer epigenetics comes of age. Nat Genet 21: 163-167.
24. Li LC, Dahiya R, (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics 18: 1427-1431.
25. Hall GL, Shaw RJ, Field EA, Rogers SN, Sutton DN, et al. (2008) p16 Promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia. Cancer Epidemiol Biomarkers Prev 17: 2174-2179.
26. Parrella P, la Torre A, Copetti M, Valori VM, Barbano R, et al. (2009) High specificity of quantitative methylation-specific PCR analysis for MGMT promoter hypermethylation detection in gliomas. J Biomed Biotechnol 2009: 531692.
27. Shaw RJ, Akufo-Tetteh EK, Risk JM, Field JK, Liloglou T, (2006) Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing. Nucleic Acids Res 34: e78.